pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Approval · news · pharmadog
← back to Approval
News · Approval
1,552
stories
Aug 7, 26
FDA to hold adcomm for Grail cancer test that failed in large, randomized trial
endpoints
Aug 7, 26
Replimune to ride wave of physician support to launch advanced melanoma therapy
biospace
Aug 7, 26
STAT+: Pharmalittle: We’re reading about Replimune’s melanoma drug, a Medicare policy change, and more
stat
Aug 7, 26
Is the biotech capital of the world moving?
stat
Aug 7, 26
Latigo IPO raises nearly $350M for pain drug development
biopharma dive
Aug 7, 26
BlossomHill, Latigo outshine IPO expectations with oversubscribed debuts
fiercebiotech
Aug 7, 26
This Week at FDA: Inspection reorg, acting CBER chief eyes IND reforms, and more
raps
Aug 6, 26
Replimune rebounds to win FDA approval of melanoma drug
biopharma dive
Aug 6, 26
Third time’s the charm for Replimune as melanoma drug earns FDA greenlight
biospace
Aug 6, 26
Replimune wins FDA approval after melanoma drug was twice rejected
endpoints
Aug 6, 26
STAT+: FDA approves Replimune melanoma drug previously rejected twice
stat
Aug 6, 26
FDA Approves New Engineered Viral Immunotherapy for Patients with Treatment-Resistant Advanced Melanoma
fda press
Aug 6, 26
Alkeus, an unorthodox eye drug startup, acquired by Tarsus for up to $800M
biopharma dive
Aug 6, 26
Takeda approval ushers in new wave of sleep drugs
biopharma dive
Aug 6, 26
STAT+: Two FDA approvals — a new drug and a new vaccine
stat
Aug 6, 26
Takeda’s narcolepsy nod opens orexin doors
biospace
Aug 6, 26
STAT+: Pharmalittle: We’re reading about Moderna’s flu shot, a death in a gene-editing trial in China, and more
stat
Aug 6, 26
Sanofi pauses mid-stage lung study amid new CEO’s ‘rigorous portfolio prioritization’
biospace
Aug 6, 26
Opinion: One year since Kennedy canceled mRNA vaccine projects, science shows how wrong he was
stat
Aug 6, 26
Covid can reactivate dormant viruses, according to study
stat
Aug 6, 26
Moderna’s flu shot crosses FDA finish line, bouncing back from regulatory roadblock
biospace
Aug 6, 26
FDA approves Moderna’s mRNA flu vaccine
biopharma dive
Aug 6, 26
Double shot of Vistagen’s anxiety nasal spray can’t beat placebo in ph. 2 trial
fiercebiotech
Aug 6, 26
FDA approves Moderna flu vaccine after spat with past agency leaders
endpoints
Aug 6, 26
FDA approves Moderna’s mRNA flu vaccine, the first to use the technology
stat
Aug 6, 26
Revolution Medicines preps for launching pancreatic cancer drug, ups 2026 expenses
endpoints
Aug 6, 26
Recon: FDA approves first drug for type 1 narcolepsy, mRNA flu vaccine; No merger talks between AstraZeneca-BMS
raps
Aug 5, 26
FDA approves Takeda's orexin drug for narcolepsy
endpoints
Aug 5, 26
STAT+: Takeda’s narcolepsy drug approved by the FDA, seen as a boon for new class of treatments
stat
Aug 5, 26
FDA Approves First Drug to Treat the Full Range of Narcolepsy Type 1 Symptoms
fda press
← prev
page 34 of 52
next →